Summit Wealth Group (Colorado)’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
Summit Wealth Group (Colorado)'s GSK Position: Q3 2026 in Review
Summit Wealth Group (Colorado) increased its GSK (GSK) stake by 18% in Q3 2026, buying an estimated $44.7K and bringing the position to 5,867 shares worth $283K. The position accounts for 0.02% of the portfolio, ranked #359.
Summit Wealth Group (Colorado) first reported a position in GSK in Q4 2025 and has held it in 4 quarters since. 992 funds tracked by Wall St. Rank hold GSK as of Q3 2026.
- Summit Wealth Group (Colorado) held 5,867 shares of GSK worth $283K as of Q3 2026.
- Summit Wealth Group (Colorado) bought 875 GSK shares in Q3 2026, an estimated $44.7K.
- GSK made up 0.02% of Summit Wealth Group (Colorado)'s portfolio in Q3 2026, its #359 holding.
- Summit Wealth Group (Colorado) first reported a position in GSK in Q4 2025 and has held it in 4 quarters since.
- 992 funds tracked by Wall St. Rank held GSK as of Q3 2026.
Based on Summit Wealth Group (Colorado)'s 13F filing for Q3 2026, filed 29 Oct 2026.